Sort   by:  
 Page size 
UnknownSeroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Not available
S-EPMC8555371 | biostudies-literature
UnknownSpecchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
Not available
S-EPMC8804307 | biostudies-literature
UnknownSeroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
Not available
S-EPMC9714630 | biostudies-literature
UnknownPersistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study.
Not available
S-EPMC9679867 | biostudies-literature
UnknownLong term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection.
Not available
S-EPMC10212737 | biostudies-literature
UnknownCovid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout: a cross-sectional analysis of a cohort study.
Not available
S-EPMC11756113 | biostudies-literature
UnknownLarge variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Not available
S-EPMC8187639 | biostudies-literature
UnknownPrevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic: a cross-sectional population-based study in Geneva, Switzerland.
Not available
S-EPMC11749439 | biostudies-literature
UnknownSerology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
Not available
S-EPMC7833057 | biostudies-literature
Sort   by:  
 Page size